Manager of Research Clinical Support Operations

Manager of Research Clinical Support Operations

Join to apply for the Manager of Research Clinical Support Operations role at Mc Kesson

It’s More Than a Career, It’s a Mission.

Our people are the foundation of our success. By joining our growing team at Sarah Cannon Research Institute (SCRI), a subsidiary of McKesson, you will have the opportunity to become part of one of the largest community-based cancer programs to advance oncology treatments and improve outcomes for cancer patients across the globe. We look for mission-driven candidates who have a desire to advance the fight against cancer and make a difference in the lives of patients diagnosed with cancer every day.

People who live with cancer – those who work to prevent it, fight it, and survive it – are at the heart of every decision we make. Bringing the most innovative medical minds together with the most passionate caregivers in their communities, we are transforming care and personalizing treatment. Through clinical excellence and cutting‑edge research, SCRI is redefining cancer care around the world.

As the Manager of Clinical Support Operations you will oversee and manage nursing support for early phase research team and research patients through subject follow up for non‑transitioned clinical trials. You will manage an interdisciplinary team to support early phase SAE reporting and follow up documentation, protocol amendment reconsents, query resolution, deviation reporting, patient reimbursement, telephone triage and other tasks supporting care of clinical trial patients.

• You will provide direct supervision, training and development of the Clinical Support Services team
• You will provide oversight, leadership, and support of organizational processes to ensure the delivery of quality research in a compliant manner
• You will define and execute departmental goals
• You will oversee and manage day‑to‑day activities of the Phase II/III research nurses including oversight and planning of needed resources to support patient care
• You will execute plan for reassignment of staff within Clinical Support team based on workload and business need
• You will ensure coverage of all tasks for which the Clinical Support team is responsible
• You will problem solve issues as they arise
• You will meet with Director weekly to communicate key issues and potential solutions, progress and risks related to late phase research patients, SAE reporting, reconsenting, query resolution, deviation reporting, reimbursement and telephone triage and other clinical support tasks
• You will meet with leadership team as needed on strategies for process improvement and execute changes with clinical support team
• You will monitor and assist with queries from internal colleagues, sponsors and CROs
• You will develop, maintain, and report out performance metrics and expectations to leadership on a regular basis for clinical support team
• You will create, monitor and maintain departmental SOPs/work instructions
• You will complete protocol training, as needed per standard operating procedure

• Knowledge of oncology/research operational and clinical proficiency
• Knowledge of good clinical practices (GCP)
• Knowledge of research protocol interpretation, and Sarah Cannon organizational policies
• General knowledge of research regulatory and Quality Assurance guidelines
• Proficiency with computer systems, including Microsoft Office, electronic data capture, Outlook, and clinical trial databases
• Current RN license is preferred
• Associate Degree required;
  Bachelor Degree preferred

$93,300 - $110,000 annually

Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 750 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer…